With this first post in the New Year, I thought I would touch on a topic which has been revolving in my mind for quite a while, and which has been incubating since Boustead announced their Bio-Treat and Big Box deals. I would readily admit that the main content for this post comes from observations and analytical thoughts stemming from the failed investment in Big Box, as well as the investment decision for Bio-Treat. These two events, coupled with my own personal experiences in negotiating and observing how deals are made, compelled me to write something on this in order to start a fruitful and engaging discussion. Deal-making is the process by which top management such as CEOs and Managing Directors engage in (sometimes) long, protracted discussions and negotiations with third-parties on potential M&A deals. As readers would already know, some of the really large mega-deals involving mergers (such as ......